Angle Share News (AGL)

Angle Information

Buy AGL Shares
Add AGL to Watchlist
Add AGL to Alert

Share Price Information for Angle (AGL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 14.00

Bid: 13.50

Ask: 14.50

Change: -0.50 (-3.45%)

Spread: 1.00 (7.407%)

Open: 14.50

High: 14.50

Low: 14.00

Prev. Close: 14.50

Last checked at -

IN BRIEF: Angle to raise GBP20 million through shares placing

Thu, 24th Jun 2021 19:30

Angle PLC - Guildford, England-based liquid biopsy company - Launches a placing to raise gross proceeds of up to GBP20 million at a price of 116 pence each. The company says it will issue 17.2 million shares at a price which represents a discount of 6.8% to the closing mid-market price of its shares of 124.50p on Wednesday. finnCap and WG Partners are acting as joint brokers to the company alongside Beech Hill Securities, which is acting as US broker to the company. Angle says it intends to use the proceeds of the placing to progress commercialisation of the Parsortix system.

Current stock price: 125.00p

Year-to-date change: more than doubled from 47.75p on December 31

By Evelina Grecenko; evelinagrecenko@alliancenews.com

More News

12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

17 Feb 2020 15:25

Angle upbeat on German research into 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Monday that University Medical Centre Hamburg-Eppendorf has published results of work undertaken to assess the analytical and clinical performance of 'Parsortix' in multiple metastatic cancer types, with the main emphasis on metastatic breast cancer.

11 Feb 2020 10:51

Latest Share Chat

Angle Share News (AGL)

Share Price Information for Angle (AGL)

IN BRIEF: Angle to raise GBP20 million through shares placing

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

Angle upbeat on recent research using 'Parsortix'

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Angle works with skeleton R&D crew during lockdown

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle upbeat on recent Parsortix research out of Italy

Angle upbeat on German research into 'Parsortix'

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Angle upbeat on research into Parsortix with melanoma patients

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

UK Earnings, Trading Statements Calendar - Next 7 Days

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Latest Share Chat

Angle Share News (AGL)

Share Price Information for Angle (AGL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Angle to raise GBP20 million through shares placing

Login to your account

Quickpicks are a member only feature

Login to your account